Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
US OptionsDetailed Quotes
STOK250516C7500
- 2.20
- 0.000.00%
15min DelayClose Apr 30 16:00 ET
0.00High0.00Low
2.20Open2.20Pre Close0 Volume93 Open Interest7.50Strike Price0.00Turnover184.29%IV-0.61%PremiumMay 16, 2025Expiry Date2.26Intrinsic Value100Multiplier16DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8106Delta0.0719Gamma3.55Leverage Ratio-0.0327Theta0.0023Rho2.88Eff Leverage0.0055Vega
Stoke Therapeutics Newsroom
Stoke Therapeutics (STOK) Upgraded to Buy: What Does It Mean for the Stock?
$STOK Stock Is up 10% Today. Here's What We See in Our Data.
Stoke Therapeutics Analyst Ratings
Stoke Therapeutics, Inc. (NASDAQ:STOK) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely
Stoke Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
CCORF Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $20
Stoke Therapeutics Remains Significantly Undervalued, Says Canaccord
Growth Investors: Industry Analysts Just Upgraded Their Stoke Therapeutics, Inc. (NASDAQ:STOK) Revenue Forecasts By 11%
Don't Ignore The Insider Selling In Stoke Therapeutics
Stoke Therapeutics Advances With Strong Financial Position
Stoke Therapeutics Executives Make Major Moves in Stock Sales!
Insider Sale: CHIEF MEDICAL OFFICER of $STOK Sells 3,884 Shares
Chardan Capital Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $24
H.C. Wainwright Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $47
Analysts Offer Insights on Healthcare Companies: Intensity Therapeutics, Inc. (INTS) and Stoke Therapeutics (STOK)
Stoke Therapeutics | 10-K: FY2024 Annual Report
Forecasting The Future: 7 Analyst Projections For Stoke Therapeutics
Needham Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $22
TD Cowen Maintains Stoke Therapeutics(STOK.US) With Buy Rating
Express News | Needham Reiterates Buy on Stoke Therapeutics, Maintains $22 Price Target
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
